Related Experiment Video
Updated: Apr 11, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
Enteric neuropathy associated to diabetes mellitus
Diabetes mellitus (DM) causes gastrointestinal (GI) dysmotility and enteric neuropathy by damaging the enteric nervous system (ENS). Research reviews DM-related GI issues and explores potential treatments for diabetic enteric neuropathy.
Area of Science:
- Gastroenterology and Endocrinology
- Neuroscience
- Diabetology
Background:
- Diabetes mellitus (DM) is a prevalent condition with diverse complications.
- Gastrointestinal (GI) dysmotility and enteric neuropathy are recognized complications of DM.
- These complications stem from damage to the enteric nervous system (ENS).
Purpose of the Study:
- To review current knowledge on GI dysmotility and enteric neuropathy in diabetes mellitus.
- To describe functional and structural alterations in the digestive tract of diabetic patients and animal models.
- To summarize therapeutic and preventive strategies for enteric diabetic neuropathy.
Main Methods:
- Literature review of studies on diabetes mellitus, GI dysmotility, and enteric neuropathy.
- Analysis of functional and structural changes in the digestive tract.
- Summary of therapeutic interventions and preventive strategies.
Main Results:
- Diabetes mellitus significantly impacts GI function and structure.
- Damage to the enteric nervous system (ENS) is a key feature of diabetic GI complications.
- Loss of inhibitory intrinsic gut innervation is a prominent alteration in DM.
Conclusions:
- Diabetic enteric neuropathy involves significant alterations in gut innervation.
- Potential therapeutic strategies include insulin, nerve growth factor, antioxidants, and myenteric neuron transplantation.
- Further research is needed to effectively manage GI complications in diabetes mellitus.
More Related Videos
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
06:21Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Psychoneuroimmunology: Diabetes and Cancer